This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1990 Apr 14;335(8694):921.

doi: 10.1016/0140-6736(90)90523-8.

Hepatitis C antibody and transaminase activities in blood donors

C Morgan, C Hyland, I F Young

PMID: 1970011
DOI: 10.1016/0140-6736(90)90523-8

Comparative Study

Hepatitis C antibody and transaminase activities in blood donors

C Morgan et al. Lancet. 1990.

. 1990 Apr 14;335(8694):921.

doi: 10.1016/0140-6736(90)90523-8.

Authors

C Morgan, C Hyland, I F Young

PMID: 1970011
DOI: 10.1016/0140-6736(90)90523-8

No abstract available

PubMed Disclaimer

Similar articles

Anti-HCV and transaminase testing of blood donors.
Kakaiya R, Gudino MD, Miller WV. Kakaiya R, et al. Lancet. 1990 Jul 21;336(8708):187-8. Lancet. 1990. PMID: 1973511 No abstract available.
[Incidence of an antigen/antibody system characterizing 1 subgroup of posttransfusion non-A, non-B hepatitis].
Renger FG, Raabe A, Forster H, Knot E. Renger FG, et al. Vutr Boles. 1986;25(5):62-4. Vutr Boles. 1986. PMID: 2433838 Bulgarian. No abstract available.
Type 2 autoimmune hepatitis and hepatitis C virus infection.
Vento S, Di Perri G, Luzzati R, Garofano T, Concia E, Bassetti D. Vento S, et al. Lancet. 1990 Apr 14;335(8694):921-2. doi: 10.1016/0140-6736(90)90524-9. Lancet. 1990. PMID: 1970012 No abstract available.
Viral markers of hepatitis.
Velasco M. Velasco M. Lab Res Methods Biol Med. 1983;7:103-17. Lab Res Methods Biol Med. 1983. PMID: 6413796 Review. No abstract available.
[Clinical aspects and risk factors in posttransfusion hepatitis].
Realdi G, Tremolada F, Chiappetta F, Antona C, Noventa F, Loreggian M, Chemello L, Alberti A. Realdi G, et al. Ric Clin Lab. 1984;14 Suppl 1:17-35. Ric Clin Lab. 1984. PMID: 6330858 Review. Italian. No abstract available.

See all similar articles

Cited by

Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.
Antonelli A, Ferrari SM, Giuggioli D, Di Domenicantonio A, Ruffilli I, Corrado A, Fabiani S, Marchi S, Ferri C, Ferrannini E, Fallahi P. Antonelli A, et al. World J Diabetes. 2014 Oct 15;5(5):586-600. doi: 10.4239/wjd.v5.i5.586. World J Diabetes. 2014. PMID: 25317237 Free PMC article. Review.
Hepatitis C virus infection is the major cause of severe liver disease in India.
Tandon BN, Irshad M, Acharya SK, Joshi YK. Tandon BN, et al. Gastroenterol Jpn. 1991 Jul;26 Suppl 3:192-5. doi: 10.1007/BF02779297. Gastroenterol Jpn. 1991. PMID: 1909266
Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein.
Hosein B, Fang CT, Popovsky MA, Ye J, Zhang M, Wang CY. Hosein B, et al. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3647-51. doi: 10.1073/pnas.88.9.3647. Proc Natl Acad Sci U S A. 1991. PMID: 1850834 Free PMC article.
Prevalence of antibodies to recombinant hepatitis C virus protein C100-3 and of elevated transaminase levels in blood donors from Northern Germany.
Caspari G, Beyer J, Richter K, Gerlich WH, Schmitt H. Caspari G, et al. Med Microbiol Immunol. 1991;180(5):261-72. doi: 10.1007/BF00202560. Med Microbiol Immunol. 1991. PMID: 1762605
Hepatitis B and C virus infection in patients with high serum transaminases.
Skliros EA, Sotiropoulos A, Lionis C, Tassopoulos NC. Skliros EA, et al. Postgrad Med J. 1998 Aug;74(874):511. doi: 10.1136/pgmj.74.874.511. Postgrad Med J. 1998. PMID: 9926136 Free PMC article. No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information